Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Using Immunoassay technique to determine clinical efficacy of a biosimilar Filgrastim with reference Filgrastim

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: ABOTALEB, Abdalla (Ministry of health, post marketing survillance, cairo, Egypt)
  • Co-author(s): Nahla kotb: Lot release, NORCB, cairo, Egypt
    Abdalla Abotaleb: post marketing survillance, NORCB, cairo, Egypt
    Doaa Mohamed: Lot release, NORCB, cairo, Egypt
  • Abstract:

    Backgrounds

    Over the next few years, the field of Biosimilars is expected to rapidly expand with the imminent patent expiry of a number of important biopharmaceuticals. Which raise a question 

    How regulatory body use a simple, accurate, effective technique to Guarantee   safety and efficacy of Biosimilars products?

    Aims

    Conducting methods can help


    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses